Back to Search Start Over

Antenatal prognostic factor of fetal echogenic bowel

Authors :
Fabien Stenard
Pascal de Lagausie
Florence Bretelle
Nicole Philip
Pascale Hoffmann
Anderson Loundou
Pierre Mace
Isabelle Mortier
Jonathan Lopater
Marie Christine Pellissier
Sabine Sigaudy
Claude D'Ercole
M. Capelle
Thierry Merrot
Candice Ronin
Annie Levy
Service de Génétique
Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE)
Génétique Médicale et Génomique Fonctionnelle (GMGF)
Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE)
Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48
INSB-INSB-Centre National de la Recherche Scientifique (CNRS)
Gynépole
Aix Marseille Université (AMU)- Hôpital Nord [CHU - APHM]
Babolat VS
Centre de Recherche Saint-Antoine (UMRS893)
Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)
CHU Saint-Antoine [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Unité d'Aide Méthodologique
Assistance Publique - Hôpitaux de Marseille (APHM)-CHU Marseille
Département de génétique médicale [Hôpital de la Timone - APHM]
Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Service d'Obstétrique-Gynécologie [Marseille]
Assistance Publique - Hôpitaux de Marseille (APHM)-CHU Marseille- Hôpital Nord [CHU - APHM]
Biologie du Cancer et de l'Infection (BCI )
Institut de Recherche Interdisciplinaire de Grenoble (IRIG)
Direction de Recherche Fondamentale (CEA) (DRF (CEA))
Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA))
Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut National de la Santé et de la Recherche Médicale (INSERM)
Laboratoire d’Aide à la Procréation, Département de Génétique et Procréation (CECOS)
Hôpital Couple Enfant de Grenoble-CHU de Grenoble
Department of Obstetrics and Gynaecology, University Hospital of Grenoble, La Tronche, France
UMR 6578 : Anthropologie Bio-Culturelle (UAABC)
Université de la Méditerranée - Aix-Marseille 2-Centre National de la Recherche Scientifique (CNRS)
Service de Chirurgie et Radiologie Pédiatrique
Université de la Méditerranée - Aix-Marseille 2
Pédiatrie et oncologie pédiatrique [Hôpital de la Timone - APHM]
Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE)
Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut de Recherche Interdisciplinaire de Grenoble (IRIG)
Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)
Source :
European Journal of Obstetrics & Gynecology and Reproductive Biology, European Journal of Obstetrics & Gynecology and Reproductive Biology, Elsevier, 2017, 212, pp.166-170. ⟨10.1016/j.ejogrb.2017.01.060⟩, European Journal of Obstetrics & Gynecology and Reproductive Biology, 2017, 212, pp.166-170. ⟨10.1016/j.ejogrb.2017.01.060⟩
Publication Year :
2017
Publisher :
HAL CCSD, 2017.

Abstract

International audience; Objective: The aim of this study was to identify antenatal prognostic factors of neonatal outcomes in cases of fetal echogenic bowel (FEB). Study design: A retrospective study in three tertiary referral centers including fetal echogenic bowel over a 10-year period (from January 2003 to December 2013). The echogenicity of the fetal bowel was graded from 1 to 3, according to Slotnick's definition. Associated echographic findings such as bowel dilations, gallbladder abnormalities, calcifications, extra-abdominal abnormalities, intrauterine growth restriction (IUGR) and a decrease in amniotic fluid volume, if present were also recorded. This was followed by the FEB's sonographic evolution. The sonographic evolution was considered favorable if it was stable or decreasing and unfavorable if the echogenicity of the bowel increased or if additional sonographic findings appeared. Neonates had a pediatric examination in the delivery room and upon discharge from the maternity hospital. An outcome was considered good in the case of on-term delivery of a newborn with normal clinical examination and meconium elimination. Results: Complete pregnancy outcome data were available for 409 pregnancies. 338 newborns had uneventful outcomes (82.6%). Antenatal exploration diagnosed 4 cases of aneuploidy (1 case of trisomy 13, 1 case of trisomy 18 and 2 cases of triploidies), 16 cases of congenital infections, 9 cases of cystic fibrosis and 11 cases of bowel abnormalities. After a multivariate analysis, we discovered the sonographic grade of the echogenic bowel was not a prognostic factor of neonatal outcome. The isolated fetal echogenic bowel had a 6.6-fold increase chance of uneventful outcomes (adjusted odd ratio (aOR) 6.6, 95% CI 3-14.4). Notably, favorable sonographic evolution (aOR 8.1, 95% CI 4.1-16) and late gestational age at the time of the diagnosis (aOR 1.17, 95% CI 1.07-1.27) are independent, good prognostic factors of good neonatal outcomes. None of the 180 fetuses with isolated fetal echogenic bowel and favorable sonographic evolution had adverse outcomes. Among these, 4 cases (0.98%) of aneuploidy, 17 cases (4.2%) of congenital infections and 9 cases (2.2%) of cystic fibroses were also diagnosed. No cases of Down syndrome (DS) were reported. Conclusion: Our study shows that the grade should not be considered a prognostic factor of neonatal outcomes. Our data suggests the need to reevaluate the concept of systematic amniocentesis. Sonographic evolution of fetal bowel is an independent, strong prognostic factor for good neonatal outcomes. It also better defines the FEB prognostic. (C) 2017 Elsevier B.V. All rights reserved.

Details

Language :
English
ISSN :
03012115
Database :
OpenAIRE
Journal :
European Journal of Obstetrics & Gynecology and Reproductive Biology, European Journal of Obstetrics & Gynecology and Reproductive Biology, Elsevier, 2017, 212, pp.166-170. ⟨10.1016/j.ejogrb.2017.01.060⟩, European Journal of Obstetrics & Gynecology and Reproductive Biology, 2017, 212, pp.166-170. ⟨10.1016/j.ejogrb.2017.01.060⟩
Accession number :
edsair.doi.dedup.....d912013385082880572ff6fa56fcb931